The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
(R)-1-((1-benzyl-1H-1,2,3-triazol-4-yl)methyl)-3-hydroxy-3-phenylindolin-2-one ID: ALA5208140
PubChem CID: 168295480
Max Phase: Preclinical
Molecular Formula: C24H20N4O2
Molecular Weight: 396.45
Associated Items:
Names and Identifiers Canonical SMILES: O=C1N(Cc2cn(Cc3ccccc3)nn2)c2ccccc2[C@]1(O)c1ccccc1
Standard InChI: InChI=1S/C24H20N4O2/c29-23-24(30,19-11-5-2-6-12-19)21-13-7-8-14-22(21)28(23)17-20-16-27(26-25-20)15-18-9-3-1-4-10-18/h1-14,16,30H,15,17H2/t24-/m1/s1
Standard InChI Key: UBZVRRZFGRKQHJ-XMMPIXPASA-N
Molfile:
RDKit 2D
30 34 0 0 0 0 0 0 0 0999 V2000
-3.7103 0.8108 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.9957 1.2230 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.2812 0.8108 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.2812 -0.0137 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.9957 -0.4260 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-3.7103 -0.0137 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.4841 -0.2886 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-1.0168 0.3985 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.4841 1.0581 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.8794 1.6078 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.0443 2.4049 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.4397 2.9545 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.3573 2.7072 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.5222 1.9101 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.0824 1.3604 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.6490 1.8551 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
-0.1923 0.3985 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
-1.2367 -1.0581 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.4397 -1.2230 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.1924 -0.6733 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
0.9070 -1.0856 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
0.7146 -1.9101 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-0.0824 -1.9926 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.2643 -2.5148 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.0888 -2.3499 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.6385 -2.9545 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.4355 -2.7896 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.7103 -1.9926 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.1332 -1.3879 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.3362 -1.5528 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2 1 2 0
3 2 1 0
4 3 2 0
5 4 1 0
6 5 2 0
1 6 1 0
4 7 1 0
8 7 1 0
9 8 1 0
3 9 1 0
9 10 1 0
11 10 2 0
12 11 1 0
13 12 2 0
14 13 1 0
15 14 2 0
10 15 1 0
9 16 1 1
8 17 2 0
7 18 1 0
18 19 1 0
20 19 1 0
20 21 2 0
21 22 1 0
22 23 1 0
23 19 2 0
22 24 1 0
25 24 1 0
25 26 1 0
26 27 2 0
27 28 1 0
29 28 2 0
30 29 1 0
25 30 2 0
M END Associated Targets(Human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: Topical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 396.45Molecular Weight (Monoisotopic): 396.1586AlogP: 3.11#Rotatable Bonds: 5Polar Surface Area: 71.25Molecular Species: NEUTRALHBA: 5HBD: 1#RO5 Violations: ┄HBA (Lipinski): 6HBD (Lipinski): 1#RO5 Violations (Lipinski): ┄CX Acidic pKa: 11.24CX Basic pKa: 0.03CX LogP: 3.46CX LogD: 3.46Aromatic Rings: 4Heavy Atoms: 30QED Weighted: 0.56Np Likeness Score: -0.97
References 1. Busto N, Leitão-Castro J, García-Sosa AT, Cadete F, Marques CS, Freitas R, Burke AJ.. (2022) N -1,2,3-Triazole-isatin derivatives: anti-proliferation effects and target identification in solid tumour cell lines., 13 (8.0): [PMID:36092141 ] [10.1039/d2md00044j ]